首页> 外文期刊>Prostaglandins, Leukotrienes, and Essential Fatty Acids >Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation
【24h】

Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation

机译:补充六个月的EPA和DHA对高甘油三酯血症受试者的Omega-3指数升高和甘油三酯降低之间的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Ingestion of long-chain n-3 PUFA effectively decreases serum triacylglycerol (TAG) levels and increases the Omega-3 Index, defined as the % of EPA and DHA in erythrocyte fatty acids. However, it remains unclear whether there is a relationship between the Omega-3 Index increase (AO3I increase) and the TAG level decrease (ATAG). We hypothesized that TAG reduction is strongly depended on Omega-3 Index increase.Subjects and methods: Secondary analyses of data from a former double-blind placebo-controlled trial in which 150 dyslipidemic statin-treated subjects were randomized to four capsules offish oil daily either as re-esterified TAG or ethylesters in identical doses (1.01 g EPA+0.67 g DHA) or corn oil as a placebo for a period of six month.Results: 108 subjects fulfilled the criteria of the current study protocol and were included in the analyses. A weak but significant negative correlation between AO3I and ATAG was observed (r= -0.211, p < 0.05). However, the relation between AO3I and serum ATAG was not linear (coefficients of determination R2: 0.044). After sub-grouping the study population into Omega-3 Index response groups, the group with a mean AO3I of > 4% after six months of n-3 PUFA treatment demonstrated the greatest TAG reduction. Discussion and conclusions: A weak association between Omega-3 Index increase and TAG level decrease was found. This may be explained by highly fluctuating TAG levels, a large inter-individual difference in response of the Omega-3 Index, a cohort of subjects with only slightly elevated TAG levels and high Omega-3 Index values at baseline, and possibly to insufficient statistical power. Since there was no strong association between Omega-3 Index increase and the TAG level decrease, we conclude that changes in serum TAG levels are not a viable substitute for the Omega-3 Index to monitor treatment with EPA and DHA.
机译:简介:摄入长链n-3 PUFA可有效降低血清三酰甘油(TAG)水平并提高Omega-3指数,Omega-3指数定义为红细胞脂肪酸中EPA和DHA的百分比。但是,尚不清楚Omega-3指数升高(AO3I升高)与TAG水平降低(ATAG)之间是否存在关系。我们假设TAG的减少在很大程度上取决于Omega-3指数的增加。研究对象和方法:对以前的一项双盲安慰剂对照试验的数据进行二次分析,该试验中150名接受降血脂药的他汀类药物治疗的受试者每天随机分成四粒鱼油作为再酯化的TAG或相同剂量(1.01 g EPA + 0.67 g DHA)的乙基酯或作为安慰剂的玉米油,为期六个月。结果:108名受试者符合当前研究方案的标准,并包括在分析中。观察到AO3I和ATAG之间的弱但显着的负相关(r = -0.211,p <0.05)。然而,AO3I和血清ATAG之间的关系不是线性的(测定系数R2:0.044)。将研究人群分为Omega-3指数反应组后,经过n-3 PUFA治疗六个月后,平均AO3I> 4%的组显示出最大的TAG减少。讨论与结论:发现Omega-3指数升高与TAG水平降低之间存在弱关联。这可能是由于TAG水平高度波动,个体间Omega-3指数反应差异较大,队列中的TAG水平仅略微升高且Omega-3指数值较高而可能是由于统计学不足所致功率。由于Omega-3指数升高与TAG水平降低之间没有密切的关联,因此我们得出结论,血清TAG水平的变化不是Omega-3指数监测EPA和DHA治疗的可行替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号